Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.4M | $25.0M | $68.2M | $147.7M | $216.8M | $279.6M | $460.4M | $516.3M |
| Cost of revenue | $16.5M | $27.9M | $50.1M | $80.1M | $118.1M | $198.3M | $348.7M | $417.3M |
| Gross profit | −$8.1M | −$2.8M | $18.1M | $67.6M | $98.7M | $81.3M | $111.8M | $99.0M |
| Gross margin | -97.2% | -11.3% | 26.5% | 45.8% | 45.5% | 29.1% | 24.3% | 19.2% |
| R&D | $42.8M | $44.6M | $46.5M | $63.5M | $141.5M | $240.6M | $416.1M | $402.1M |
| Operating income | −$89.5M | −$100.2M | −$121.3M | −$122.6M | −$244.1M | −$652.2M | −$778.3M | −$714.2M |
| EBITDA | −$89.5M | −$93.6M | −$121.6M | −$111.6M | −$235.7M | −$677.8M | −$391.6M | −$2.89B |
| Net income | −$89.8M | −$100.3M | −$123.4M | −$129.4M | −$242.0M | −$608.9M | −$379.0M | −$3.11B |
| Net margin | -1071.6% | -400.3% | -180.9% | -87.6% | -111.6% | -217.8% | -82.3% | -601.6% |
| EPS (diluted) | -3.18 | -3.02 | -2.65 | -1.94 | -2.66 | -4.52 | -1.80 | -13.18 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds NVTA.
No tracked institution reports a position in NVTA as of their last filing.
No one on the platform has traded NVTA yet.
| $5M |
| — |
| NUVOHoldco Nuvo Group D.G Ltd. Ordinary Shares | $0.17 | +100.00% | $6M | — |
| OBLNObalon Therapeutics, Inc. | $3.05 | -5.86% | $5M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.